Complexity of the genomic landscape of renal cell carcinoma: Implications for targeted therapy and precision immuno-oncology

Joseph M. Sanfrancesco, Liang Cheng

Research output: Contribution to journalReview article

10 Scopus citations

Abstract

The topic of tumoral heterogeneity at the genetic level has become relevant in various solid origin tumors, particularly in an age of targeted treatment. Renal cell carcinoma is known for a sizable subset of tumors presenting at advanced clinical stage, further highlighting the importance and timeliness of this topic and its potential impact on adjuvant therapy. Recent studies have shown that molecular aberrations in renal cell carcinoma go beyond known truncal mutations and that downstream, subclonal aberrations are spatially heterogenous. Intratumoral heterogeneity as well as the differences in the molecular landscape between primary and metastatic lesions remains underappreciated, often due to inadequate sampling of tumors. The overall effect of these factors on the efficacy of current treatment options in renal cell carcinoma remains unknown; however, several recent studies have attempted to elucidate the extent and impact genetic heterogeneity in renal cell neoplasia may have on patient treatment and prognosis.

Original languageEnglish (US)
Pages (from-to)23-28
Number of pages6
JournalCritical Reviews in Oncology/Hematology
Volume119
DOIs
StatePublished - Nov 1 2017

Keywords

  • Clonal evolution
  • Kidney
  • Precision immuno-oncology
  • Renal cell carcinoma
  • Targeted therapy
  • Tumor heterogeneity

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Geriatrics and Gerontology

Fingerprint Dive into the research topics of 'Complexity of the genomic landscape of renal cell carcinoma: Implications for targeted therapy and precision immuno-oncology'. Together they form a unique fingerprint.

  • Cite this